12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cobas HPV test regulatory update

Roche said its cobas 4800 HPV test received CE Mark approval as a primary screen to identify women at highest risk for cervical cancer....

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >